The company for sale is relatively a young company in the market specialized in the distribution of pharma products. The management of this company is willing to make a strategic sale although private equity sale for growth finance is also on the agenda.
In case the strategic sale does not go through, the company management will activate the business plan of IPO in order to secure financing for expansion as an obvious requirement for pharma distribution companies when they plan to open new branches and depots. The company’s previous ownership structure involved a high number of partners which was restructured through a buyback share program which was buying back shares of 30 partners, thus there arose a need for capital as the previous financial cashflow used for buyback shares. The ideal buyer is most likely a European or US based pharma distributor that has an interest in the home market of the company for sale.
The company for sale is a pharma distributor established approximately 15 years ago. Throughout the years, the company has concluded agreements with manufacturers and importers to meet needs of its customers. The company is able to ship and keep medicines in accordance with the relevant orders of the Ministry of Health in Turkey.
The company for sale has a 3 floor facility building which is spread over a total area of 1,200 m2 and 7 company owned commercial vehicles to run the distribution operations as well as 4 vehicles on lease. As of today, the company for sale does not have any branch, but for the near future, the partners look forward to expanding based on new branch establishments.
Contact us to get details about this pharma distributor in Turkey for sale
The company for sale distributes all types of medicine and all brands that are sold in Turkey. The company has 22 partners, however, three of them represent app. 65% of the total shares.
The company for sale has its own expansion plan with 5M EUR required in order to realize significant growth in sales. The management is planning to open 2 branches which require a larger investment that includes the rental costs and new employees. The additional capital requirement is for purchasing medicine on discount in the amount of 3M EUR. The company’s strategy will continue to be a high-quality pharma and medical supplies and devices distributor with a strong sales and marketing network in its home market. Because the distribution business is very associated with the branch/depot expansion, additional two distribution centres are estimated to generate a year’s sales of around 38 M Euros with 5% net profit margin.
Feel free to contact us for more information regarding this Pharma distributor based in Turkey for sale. If this pharma distributor based in Turkey for sale does not fit your requirements feel free to ask for other pharma distribution companies for sale. For buyers of pharma related companies please visit the section pharma companies wanted.